Dr. Raajit Rampal is an Assistant Member at Memorial Sloan Kettering Cancer Center and Clinical Director of the Leukemia Service. The focus of his research has been to utilize genetic insights from primary patient samples to elucidate mechanism of pathogenesis in acute myeloid leukemia (AML) and the Philadelphia-chromosome negative myeloproliferative neoplasms (MPN). These genetic insights are being used to develop novel models of AML and MPN, and to develop mechanism-based clinical trials.